New Application of Viable PCR for Following Early Tuberculosis Treatment
Italian researchers from San Raffaele Scientific Institute,(Milan) report an innovative approach to selectively amplify DNA derived from viable Mycobacterium tuberculosis in clinical specimens, which is useful for monitoring mycobacterial load in pulmonary TB patients during anti-TB treatment.
The procedure is based in a sample pre treatment with PMA (500uM, 30 min a 4ºC in the dark ) and 15 min of photo activation with a Geniul system. Please click here for further information.
Tags: Mycobacterium, PCR, Mycobacterium tuberculosis
Date Published: May 21, 2012
Source article link: GENIUL, S.L. » company contact details
Bruker Introduces Novel PCR Assays for Aspergillosis and Carbapenem Resistance
How to Prevent False-Positive Results in Pathogen Testing
Multiplex PCR Amplidiag® Detects Main Enteric Parasites from Stools
New Quantitative Nucleic Acids for Metapneumovirus, MERS-CoV, Bocavirus, and more!